Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Assumptions & Limitations
2.2.1 Assumptions
2.2.2 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing adoption of EHR/EMR
4.2.2 Increasing prevalence of chronic diseases like diabetes, cancer, and others
4.2.3 The dearth of physicians in the presence of increasing healthcare services demands
4.3 Restraints
4.3.1 The high cost of implementing telemedicine systems like EMR & EHR and the need for training
4.3.2 Stringent government regulations
5 Market Factor Analysis
5.1 Porter's Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Investment Opportunity Analysis
5.3 Value Chain Analysis
5.3.1 Inputs
5.3.2 Software Development Processes
5.3.3 Output
5.3.4 Marketing and Distribution
5.3.5 Post-selling Services
5.4 Regulatory Framework
5.4.1 Americas
5.4.2 Europe
5.4.2.1 Data Protection Directive
5.4.2.2 e-Commerce Directive
5.4.2.3 Medical Device Directives
5.4.2.4 Regulation on Distance Contracting
5.4.2.5 Directive on Electronic Signatures
5.4.2.6 Competition law
5.4.2.7 Directive on Professional Qualifications
5.4.2.8 Reimbursement
5.4.3 Russia
5.4.4 Asia Pacific
5.4.4.1 China
5.4.4.2 Japan
5.4.4.3 India
5.4.4.4 Australia
5.4.4.5 Singapore
5.4.4.5.1 Clinical Standards and Outcomes
5.4.4.5.2 Human Resources
5.4.4.5.3 Organisational
5.4.4.5.4 Technology and Equipment
5.4.5 The Middle East & Africa
5.4.5.1 Dubai
5.4.5.2 Abu Dhabi
6 Global Telemedicine Market, By Service Type
6.1 Introduction
6.2 Tele-Nursing
6.3 Tele-Pharmacy
6.4 Tele-Radiology
6.5 Tele-Dermatology
6.6 Tele-Oncology
7 Global Telemedicine Market, By Component
7.1 Introduction
7.2 Software
7.3 Hardware
8 Global Telemedicine Market, By Deployment
8.1 Introduction
8.2 Cloud Based
8.3 On Premises
9 Global Telemedicine Market, By Application
9.1 Introduction
9.2 Cardiology
9.3 Ophthalmology
9.4 Psychiatry
9.5 Radiology
9.6 Dermatology
10 Global Telemedicine Market, By End User
10.1 Introduction
10.2 Hospital
10.3 Clinic
10.4 Home care
11 Global Telemedicine Market: by Region
11.1 Americas
11.1.1 North America
11.1.1.1 US
11.1.1.1 Canada
11.1.2 South America
11.2 Europe
11.2.1 Western Europe
11.2.1.1 Germany
11.2.1.2 France
11.2.1.3 UK
11.2.1.4 Italy
11.2.1.5 Spain
11.2.1.6 Rest of Western Europe
11.2.2 Eastern Europe
11.3 Asia Pacific
11.3.1 China
11.3.2 India
11.3.3 Japan
11.3.4 Rest of Asia Pacific
11.4 The Middle East & Africa
11.4.1 United Arab Emirates
11.4.2 Saudi Arabia
11.4.3 Oman
11.4.4 Kuwait
11.4.5 Qatar
11.4.6 Rest of Middle East & Africa
12 Competitive Analysis
12.1 Company Market Share Analysis
12.1.1 Introduction
12.2 Competitive Landscape
12.2.1 Introduction
13 Company Profile
13.1 AMD Global Telemedicine, Inc.
13.1.1 Company Overview
13.1.2 Financials
13.1.3 Products
13.1.4 Strategy
13.1.5 Key Developments
13.2 BioTelemetry, Inc.
13.2.1 Company Overview
13.2.2 Financials
13.2.3 Products
13.2.4 Strategy
13.2.5 Key Developments
?
13.3 CareClix
13.3.1 Company Overview
13.3.2 Financials
13.3.3 Products
13.3.4 Strategy
13.3.5 Key Developments
13.4 Cerner Corporation
13.4.1 Company Overview
13.4.2 Financials
13.4.3 Products
13.4.4 Strategy
13.4.5 Key Developments
13.5 Cisco
13.5.1 Company Overview
13.5.2 Financials
13.5.3 Products
13.5.4 Strategy
13.5.5 Key Developments
13.6 GENERAL ELECTRIC
13.6.1 Company Overview
13.6.2 Financials
13.6.3 Products
13.6.4 Strategy
13.6.5 Key Developments
13.7 IBM Corporation
13.7.1 Company Overview
13.7.2 Financials
13.7.3 Products
13.7.4 Strategy
13.7.5 Key Developments
13.8 Intel Corporation
13.8.1 Company Overview
13.8.2 Financials
13.8.3 Products
13.8.4 Strategy
13.8.5 Key Developments
13.9 Iris Telehealth
13.9.1 Company Overview
13.9.2 Financials
13.9.3 Products
13.9.4 Strategy
13.9.5 Key Developments
13.1 Koninklijke Philips N.V.
13.10.1 Company Overview
13.10.2 Financials
13.10.3 Products
13.10.4 Strategy
13.10.5 Key Developments
13.11 Medtronic
13.11.1 Company Overview
13.11.2 Financials
13.11.3 Products
13.11.4 Strategy
13.11.5 Key Developments
13.12 SHL Telemedicine
13.12.1 Company Overview
13.12.2 Financials
13.12.3 Products
13.12.4 Strategy
13.12.5 Key Developments
13.13 TeleVital
13.13.1 Company Overview
13.13.2 Financials
13.13.3 Products
13.13.4 Strategy
13.13.5 Key Developments
14 MRFR Conclusion
14.1 Key Findings
14.1.1 From CEO's View Point
14.2 Key Companies to Watch
15 Appendix
15.1 Discussion Blue Print
15.2 Recent Developments, 2013-2017
